Happold, Caroline http://orcid.org/0000-0001-6181-2895
,
Gorlia, Thierry
Nabors, L. Burt
Erridge, Sara C.
Reardon, David A.
Hicking, Christine
Picard, Martin
Stupp, Roger
Weller, Michael
Article History
Received: 28 June 2017
Accepted: 1 February 2018
First Online: 8 February 2018
Compliance with ethical standards
:
: CHa has received honoraria for advisory board participation from MSD. CHi is employee of Merck KGaA. DAR has received lab support from Acerta, Agenus, Celldex, EMD Serono, Acerta, Inovio, Midatech and Tragara, and honoraria for lectures or advisory board from Abbvie, Agenus, Amgen, Bristol Myers Squibb, Cavion, Celldex, EMD Serono, Genentech/Roche, Juno Pharmaceuticals, Merck, Midatech, Inovio, Momenta Pharmaceuticals, Novartis, Novocure, Oxigene, Regeneron, Stemline Therapeutics. RS has received honoraria for advisory board participation and consulting from Roche, Merck KGaA, MSD, Merck, Pfizer, Ipsen, Novartis and AbbVie. MW has received research grants from Acceleron, Actelion, Bayer, Isarna, Merck, Sharp & Dohme, Merck (EMD, Darmstadt), Novocure, OGD2, Piqur and Roche and honoraria for lectures or advisory board participation or consulting from Abbvie, BMS, Celldex, Immunocellular Therapeutics, Magforce, Merck, Sharp & Dohme, Merck (EMD, Darmstadt), Novocure, Pfizer, Roche, Teva and Tocagen. TG, LBN, SCE, and MP declare no conflict of interest.